These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 31816408)

  • 1. NLRP3-associated autoinflammatory diseases: Phenotypic and molecular characteristics of germline versus somatic mutations.
    Louvrier C; Assrawi E; El Khouri E; Melki I; Copin B; Bourrat E; Lachaume N; Cador-Rousseau B; Duquesnoy P; Piterboth W; Awad F; Jumeau C; Legendre M; Grateau G; Georgin-Lavialle S; Karabina SA; Amselem S; Giurgea I
    J Allergy Clin Immunol; 2020 Apr; 145(4):1254-1261. PubMed ID: 31816408
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Somatic Mosaic NLRP3 Mutations and Inflammasome Activation in Late-Onset Chronic Urticaria.
    Assrawi E; Louvrier C; Lepelletier C; Georgin-Lavialle S; Bouaziz JD; Awad F; Moinet F; Moguelet P; Vignon-Pennamen MD; Piterboth W; Jumeau C; Cobret L; El Khouri E; Copin B; Duquesnoy P; Legendre M; Grateau G; Karabina SA; Amselem S; Giurgea I
    J Invest Dermatol; 2020 Apr; 140(4):791-798.e2. PubMed ID: 31513803
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Low-frequency mosaicism in cryopyrin-associated periodic fever syndrome: mosaicism in systemic autoinflammatory diseases.
    Nishikomori R; Izawa K; Kambe N; Ohara O; Yasumi T
    Int Immunol; 2019 Sep; 31(10):649-655. PubMed ID: 31185077
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy of canakinumab on AA amyloidosis in late-onset NLRP3-associated autoinflammatory disease with an I574F somatic mosaic mutation.
    Itamiya T; Komai T; Kanda H; Nagafuchi Y; Chang H; Shibata S; Ishiura H; Shoda H; Toda T; Fujio K
    Clin Rheumatol; 2022 Jul; 41(7):2233-2237. PubMed ID: 35314925
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Posttranslational Regulation of the NLR Family Pyrin Domain-Containing 3 Inflammasome.
    Shim DW; Lee KH
    Front Immunol; 2018; 9():1054. PubMed ID: 29868015
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of a selective and direct NLRP3 inhibitor to treat inflammatory disorders.
    Jiang H; He H; Chen Y; Huang W; Cheng J; Ye J; Wang A; Tao J; Wang C; Liu Q; Jin T; Jiang W; Deng X; Zhou R
    J Exp Med; 2017 Nov; 214(11):3219-3238. PubMed ID: 29021150
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Therapeutic Targeting of NLRP3 Inflammasomes by Natural Products and Pharmaceuticals: A Novel Mechanistic Approach for Inflammatory Diseases.
    Jahan S; Kumar D; Chaturvedi S; Rashid M; Wahajuddin M; Khan YA; Goyal SN; Patil CR; Mohanraj R; Subramanya S; Ojha S
    Curr Med Chem; 2017; 24(16):1645-1670. PubMed ID: 28245768
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sendai Virus V Protein Inhibits the Secretion of Interleukin-1β by Preventing NLRP3 Inflammasome Assembly.
    Komatsu T; Tanaka Y; Kitagawa Y; Koide N; Naiki Y; Morita N; Gotoh B; Yokochi T
    J Virol; 2018 Oct; 92(19):. PubMed ID: 30021903
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Advances in mechanisms for NLRP3 inflammasomes regulation].
    Liu W; Guo WJ; Xu Q; Sun Y
    Yao Xue Xue Bao; 2016 Oct; 51(10):1505-12. PubMed ID: 29924571
    [TBL] [Abstract][Full Text] [Related]  

  • 10. NLRP3 inflammasome assembly is regulated by phosphorylation of the pyrin domain.
    Stutz A; Kolbe CC; Stahl R; Horvath GL; Franklin BS; van Ray O; Brinkschulte R; Geyer M; Meissner F; Latz E
    J Exp Med; 2017 Jun; 214(6):1725-1736. PubMed ID: 28465465
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gain-of-function CEBPE mutation causes noncanonical autoinflammatory inflammasomopathy.
    Göös H; Fogarty CL; Sahu B; Plagnol V; Rajamäki K; Nurmi K; Liu X; Einarsdottir E; Jouppila A; Pettersson T; Vihinen H; Krjutskov K; Saavalainen P; Järvinen A; Muurinen M; Greco D; Scala G; Curtis J; Nordström D; Flaumenhaft R; Vaarala O; Kovanen PE; Keskitalo S; Ranki A; Kere J; Lehto M; Notarangelo LD; Nejentsev S; Eklund KK; Varjosalo M; Taipale J; Seppänen MRJ
    J Allergy Clin Immunol; 2019 Nov; 144(5):1364-1376. PubMed ID: 31201888
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tyrosine phosphatase SHP2 negatively regulates NLRP3 inflammasome activation via ANT1-dependent mitochondrial homeostasis.
    Guo W; Liu W; Chen Z; Gu Y; Peng S; Shen L; Shen Y; Wang X; Feng GS; Sun Y; Xu Q
    Nat Commun; 2017 Dec; 8(1):2168. PubMed ID: 29255148
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cholesterol Efflux Pathways Suppress Inflammasome Activation, NETosis, and Atherogenesis.
    Westerterp M; Fotakis P; Ouimet M; Bochem AE; Zhang H; Molusky MM; Wang W; Abramowicz S; la Bastide-van Gemert S; Wang N; Welch CL; Reilly MP; Stroes ES; Moore KJ; Tall AR
    Circulation; 2018 Aug; 138(9):898-912. PubMed ID: 29588315
    [TBL] [Abstract][Full Text] [Related]  

  • 14. NLRP3 Inflammasome and Inflammatory Diseases.
    Wang Z; Zhang S; Xiao Y; Zhang W; Wu S; Qin T; Yue Y; Qian W; Li L
    Oxid Med Cell Longev; 2020; 2020():4063562. PubMed ID: 32148650
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In Silico Insights towards the Identification of NLRP3 Druggable Hot Spots.
    Mekni N; De Rosa M; Cipollina C; Gulotta MR; De Simone G; Lombino J; Padova A; Perricone U
    Int J Mol Sci; 2019 Oct; 20(20):. PubMed ID: 31600880
    [TBL] [Abstract][Full Text] [Related]  

  • 16.
    Nakanishi H; Kawashima Y; Kurima K; Chae JJ; Ross AM; Pinto-Patarroyo G; Patel SK; Muskett JA; Ratay JS; Chattaraj P; Park YH; Grevich S; Brewer CC; Hoa M; Kim HJ; Butman JA; Broderick L; Hoffman HM; Aksentijevich I; Kastner DL; Goldbach-Mansky R; Griffith AJ
    Proc Natl Acad Sci U S A; 2017 Sep; 114(37):E7766-E7775. PubMed ID: 28847925
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The mechanism of NLRP3 inflammasome initiation: Trimerization but not dimerization of the NLRP3 pyrin domain induces robust activation of IL-1β.
    Sušjan P; Roškar S; Hafner-Bratkovič I
    Biochem Biophys Res Commun; 2017 Feb; 483(2):823-828. PubMed ID: 28065854
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Trimethylamine-N-Oxide Induces Vascular Inflammation by Activating the NLRP3 Inflammasome Through the SIRT3-SOD2-mtROS Signaling Pathway.
    Chen ML; Zhu XH; Ran L; Lang HD; Yi L; Mi MT
    J Am Heart Assoc; 2017 Sep; 6(9):. PubMed ID: 28871042
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Compound C attenuates NLRP3 inflammasome despite AMPK knockdown in LPS plus palmitate-induced THP-1 cells.
    Liu Y; He H; Fan L; Yuan J; Huang H; Yang W; Wang L; Mo Z; Wang F
    Naunyn Schmiedebergs Arch Pharmacol; 2020 Jan; 393(1):67-76. PubMed ID: 31420721
    [TBL] [Abstract][Full Text] [Related]  

  • 20. New insights into the nature of autoinflammatory diseases from mice with Nlrp3 mutations.
    Meng G; Strober W
    Eur J Immunol; 2010 Mar; 40(3):649-53. PubMed ID: 20201022
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.